Brooklyn Medical Institute

Brooklyn, New York 11214

We've found

3 trials

at this facility

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Brooklyn, NY

AGN-241751 in the Treatment of Major Depressive Disorder

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Brooklyn, NY

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Brooklyn, NY

Use our guide to learn which trials are right for you!